Excimer laser combined with drug coated balloon in the treatment of arteriosclerosis obliterans of lower extremities

VernacularTitle:准分子激光联合药涂球囊治疗下肢动脉硬化闭塞的临床疗效分析
Author: Yan GU ¹ ; Ju HE ; Hui LIU
Author Information

1. 天津市第一中心医院血管外科　300192
From: Chinese Journal of General Surgery 2020;35(8):640-643
CountryChina
Language:Chinese
Abstract: Objective:To evaluate the efficacy and safety of excimer laser ablation (ELA) combined with drug-eluting balloon angioplasty in the treatment of arteriosclerosis obliterans of lower extremities.Methods:The clinical data of 17 patients who received ELA from May to Dec 2017 was retrospectively analyzed, including 12-month primary patency rate, technical success rate, surgical success rate, stent implantation rate, target vessel reintervention rate and major adverse events.Results:The length of lesions was (23.3±8.9) cm. The success rate of technique and operation was 100%.All cases were treated with combined DCB. Five cases underwent stent placement, and the patency rate at 12 months was 82.4%. The recurrence rate of target lesion was 5.9%.Conclusion:ELA combined with DCBA is safe and feasible in the treatment of lower extremity arterial occlusive disease.